| Entity Name: | IMMUNARTES LLC |
| Jurisdiction: | Illinois |
| Entity Type: | Limited Liability Company |
| Status: | Goodstanding |
| Date Formed: | 14 Jun 2024 |
| Company Number: | LLC_14045449 |
| File Number: | 14045449 |
| Type of Management: | Manager Managed |
| Date Status Change: | 14 Jun 2024 |
| Address | 400 N ABERDEEN STREET, SUITE 900, CHICAGO, 60642, IL |
| Place of Formation: | DELAWARE |
| Name and Address | Role | Appointment Date |
|---|---|---|
| DOMINQUE MISSIAKAS, 6401 SOUTH GARFIELD AVENUE, WILLOWBROOK, 60527 | Agent | 2024-06-14 |
| Name and Address | Role | Appointment Date |
|---|---|---|
| MISSIAKAS, DOMINQUE, 6401 SOUTH GARFIELD AVENUE, WILLOWBROOK, IL, 60527 | Manager | 2024-06-14 |
| Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEFINITIVE CONTRACT | AWARD | 75N93022C00057 | 2022-09-21 | 2027-04-30 | 2027-04-30 | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Obligated Amount | 4308551.00 |
| Current Award Amount | 4308551.00 |
| Potential Award Amount | 11026349.00 |
Description
| Title | ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION AND COLONIZATION. |
| NAICS Code | 541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Product and Service Codes | AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
Recipient Details
| Recipient | IMMUNARTES, LLC |
| UEI | ETMGB9KR3GG4 |
| Recipient Address | UNITED STATES, 1463 E 53RD ST FL 2, CHICAGO, COOK, ILLINOIS, 606154513 |
Date of last update: 23 Dec 2024
